ALKERMES | Lånekapital

Loan Capital Endring Dato
Acadia Pharmaceuticals USD 0 0 2022-06
Amgen USD 63.17B 4.13B 2023-12
Gilead Sciences USD 23.19B 1.98B 2023-09
Intra Cellular Therapies USD 0 0 2022-06
Ionis Pharmaceuticals USD 1.23B 49.79M 2023-12
Malin Corporation EUR 0 0 2021-12
Neurocrine Biosciences USD 169.5M 500K 2023-03
Regeneron Pharmaceuticals USD 2.7B 300K 2023-12
Vertex Pharmaceuticals USD 390.3M 13.8M 2023-09



ALKERMES Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2024.